The TinyArray imager has the antibody testing accuracy of machines 100 times more expensive and can be deployed in low-resource areas around the world. Timothy Abram
Portable imager could massively increase testing across nation by end of 2020
A robust, low-cost imaging platform utilizing lab-on-a-chip technology created by University of California, Irvine scientists may be available for rapid coronavirus diagnostic and antibody testing throughout the nation by the end of the year.
The UCI system can go a long way toward the deployment of a vaccine for COVID-19 and toward reopening the economy, as both require widespread testing for the virus and its antibodies. So far, antibody testing in the U.S. has been too inaccurate or expensive to reach the necessary numbers.
But UCI investigators Weian Zhao, Per Niklas Hedde, Enrico Gratton and Philip Felgner believe that their new technology can help accelerate the testing process quickly and affordably. Their discovery appears in the journal Lab on a Chip, which is published by the Royal Society of Chemistry.
“We need to test millions of people a day, and we’re very far from that,” said Hedde, a project scientist in pharmaceutical sciences and the study’s lead author. “This accurate testing platform enables public health officers to implement individualized mitigation strategies that are needed to safely reopen the country and economy.”
How it works
Using blood from a finger prick, the UCI test probes hundreds of antibody responses to 14 respiratory viruses, including SARS-CoV-2, in a mere two to four hours. Identifying responses to viral infections with symptoms similar to those of COVID-19 will keep hospitals clear of patients with standard colds and flus.
The results are printed on a low-cost imaging platform. The TinyArray imager combines a 3D-printed prototype with an off-the-shelf LED and a small 5-megapixel camera to find markers for many antibodies simultaneously. This ensures accuracy equal to that of expensive imaging systems but makes the platform portable enough to deploy anywhere – at a cost of only $200.
The same device can also process the results of commonly used nose swab tests for SARS-CoV-2 so that patients can be tested for COVID-19 and its antibodies on a single platform.
Currently, most antibody tests only check for one or two antigens, the foreign substances that cause the body to produce antibodies.
“A month or two ago, testing was kind of regarded as the Wild West,” said Zhao, a professor of pharmaceutical sciences, adding that most SARS-CoV-2 antibody tests are “just not accurate.”
Systems that test for the full range of antibodies necessary for reliable results require imaging machines that cost $10,000 to $100,000 and are too bulky for widespread use. Areas without the resources to acquire one of these machines have to send their samples to external labs for testing, meaning that results take days instead of hours.
Big impact
Large-scale testing will determine what percentage of the population had COVID-19 but never showed symptoms, which will have a big impact on public health and reopening decisions.
“What if it turns out that a larger percentage of the people in a community have already contracted the virus?” Zhao said. “This means you are closer to accomplishing herd immunity.”
And understanding what antibodies are produced and how long they last will be key in developing an effective vaccine and administering the right dosage. This may be critical for years to come if the virus mutates, requiring updates much like yearly flu vaccinations.
The UCI team has already completed 5,000 tests in Orange County, and the final goal is to test 20,000 samples per unit a day. The researchers are partnering with UCI startups Velox Biosystems Inc. and Nanommune Inc. to scale up production. They expect that the TinyArray imager will be ready to deploy across the U.S. by the end of 2020 and are working with scientists in Uruguay, Russia and Thailand to develop similar systems for their nations.
“This would be great for a low-income country,” Hedde said. “Because the device’s materials are cheap and easy to obtain, the platform is easy to manufacture and use in low-resource areas, making testing accessible on a world scale.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID-19 testing
- Study: HIV cases along border spiked during COVID-19 pandemic
SAN DIEGO ( Border Report) — Researchers at UC San Diego and UC Irvine found that when border restrictions were in place during the COVID-19 pandemic, HIV transmissions in Tijuana and San Diego went ...
- This San Diego maker of COVID-19 tests is laying off half its workforce
The once high-flying Cue Health has struggled following a drop in demand for COVID-19 tests. It's chief financial officer also resigned last month.
- 1 in 5 Milk Samples Test Positive for Bird Flu—Here’s Why Parents Shouldn’t Worry
Traces of bird flu were recently found in commercial milk, but federal agencies and experts say it's not cause for alarm at this time.
- UK Covid-19 Inquiry: ‘Reckless’ to discharge people to care homes without Covid tests, says NI's commissioner for older people
Northern Ireland’s commissioner for older people has blasted as “reckless” cases during the pandemic where people were discharged to care homes without being tested for Covid-19.
- Standardized testing as we know it cannot return
When COVID-19 first hit the United States, finding standardized testing sites became extremely difficult. Many, including myself, signed up only for the testing site to cancel a few days before, or ...
Go deeper with Google Headlines on:
COVID-19 testing
[google_news title=”” keyword=”Covid-19 testing” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Portable Covid-19 imager
- Blanchette moving company packing up and moving on after 77 years in Lewiston
Blanchette Moving & Storage Co. owners make their final deliveries after decades of packing, lifting, driving and delivering around the country.
- Garbage is piling up on Mount Everest. These sustainable solutions are underway
The trash problem first became evident in the 1980s and 1990s, when climbing on the mountain and trekking in Khumbu began to increase.
- Medical Sensors Market worth $3.6 billion by 2029 - Exclusive Report by MarketsandMarkets™
The medical sensors market is valued at USD 2.4 billion in 2024 and is projected to reach USD 3.6 billion by 2029; it is expected to grow at a CAGR of 8.1% from 2024 to 2029 according to a new report ...
- Optomed Oyj, AEYE Health say portable device to detect eye issues gets FDA nod
A portable device that detects eye conditions that can cause sight loss in people with conditions such as diabetes has received clearance from the U.S. health regulator, its developers Optomed Oyj and ...
- How Does Kindle Work? What to Know in 2024
All Kindle screens can display images in 16 levels of gray using electronic ink technology ... At its most basic level, the Kindle is just a specialized portable computer. It has many of the bits and ...
Go deeper with Google Headlines on:
Portable Covid-19 imager
[google_news title=”” keyword=”Portable Covid-19 imager” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]